Product information
From Health Canada
Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.
Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.
Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.
- Natural Product Number (NPN):
- 80045023
- Market status:
- Marketed
- Licence Status:
- Active
- Brand name(s):
- Vitamin B12 500 mcg
- Licence holder:
- New Roots Herbal Inc.
- Dosage Form:
- Capsule
- Recommended route of administration:
-
Oral
Sub population (Sub Pop.) | Quantity (Qty) | Frequency (Freq.) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sub Pop. | Age | Min. | Max. | UoM Footnote1 Age | Qty | Min. | Max. | UoM Qty | Freq. | Min. | Max. | UoM Freq. |
Adults | 1.0 | capsule | 1 | daily | ||||||||
- Recommended use or purpose:
- Helps to form red blood cells. Helps the body to metabolize carbohydrates, fats and proteins.
- Risk Information:
- Cautions and Warnings
- Consult a health care practitioner prior to use if you have diabetes or galactosemia. Discontinue use and consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking anti-inflammatory or other enzyme products. Consult a health care practitioner prior to use if you have allergy to latex or fruits (such as avocado, banana, chestnut, passion fruit, fig, melon, mango, kiwi, pineapple, peach, and tomato). Consult a health care practitioner prior to use if you are have gastrointestinal lesions/ulcers or are having surgery. Do not use if you have liver or gall bladder disorders, and/or bowel obstruction. Discontinue use if you develop symptoms of liver trouble such as abdominal pain, dark urine or jaundice. Do not take if you have a heart condition or are on anticoagulants. Consult a health care practitioner prior to use if you are taking antibiotics.
- Contra-Indications
- Do not use if pregnant or breastfeeding; do not use after recent surgery.
- Known Adverse Reactions
- Headaches, heartburn, bloating and hypersensitivity (e.g. allergy) have been known to occur; in which case, discontinue use. Nausea, vomiting, and diarrhoea have been known to occur, in which case discontinue use. May cause bloating, cramping, and constipation.
Medicinal ingredients | Quantity (Qty) | Extract | Potency |
---|---|---|---|
1,4-alpha-D-Glucan glucohydrolase |
0.5556 mg
|
0.6667
FCC AGU
|
|
4-(1,3;1,4)-beta-D-Glucan 4-glucanohydrolase |
0.14 mg
|
16.8
FCC CU
|
|
4-alpha-D-Glucan glucanohydrolase |
1.26 mg
|
157.49
FCC DU
|
|
Bacterial Protease |
0.832 mg
|
60.0
FCC PC
|
|
Beta vulgaris |
300.0 mg
|
||
Beta-D-galactoside galactohydrolase |
0.0725 mg
|
7.25
FCC ALU
|
|
Malt diastase |
0.0433 mg
|
1.733
FCC DP
|
|
Papain |
0.04 mg
|
400.0
FCC PU
|
|
Poly(1-4-a-D-galacturonide)glycanohydrolase |
0.008 mg
|
0.8
Endo-PGU
|
|
Protease |
0.832 mg
|
552.4933
FCC HUT
|
|
Protease |
0.832 mg
|
0.76
FCC SAPU
|
|
Serratiopeptidase |
9.33E-4 mg
|
2.493333
FCC SU
|
|
Stem bromelain |
0.2667 mg
|
9600.0
FCC PU
|
|
Tabebuia heptaphylla |
50.0 mg
|
4
:
1
DHE: 200 mg |
|
Taraxacum officinale |
40.0 mg
|
10
:
1
DHE: 400 mg |
3.0
%
Flavonoids |
Triacylglycerol acylhydrolase |
0.1 mg
|
26.67
FCC LU
|
|
Vitamin B12 |
500.0 mcg
|
||
alpha-D-Galactoside galactohydrolase |
0.0169 mg
|
0.253
FCC GalU
|
|
alpha-L-arabinofuranoside arabinofuranohydrolase |
0.00107 mg
|
0.444
FCC HCU
|
|
beta-D-fructofuranoside fructohydrolase |
0.0163 mg
|
1.067
FCC INVU
|
|
myo-Inositol-hexakisphosphate 3-phosphohydrolase |
0.0167 mg
|
0.033
FCC FTU
|
- List of non-medicinal ingredients:
-
- Dicalcium phosphate
- Hypromellose
- Magnesium Stearate
- Purified water
- Silicon dioxide
- Date of licensing:
- 2013-09-26
- Revised date of licence:
- 2014-07-09
Application information
Related information
Contact us
For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).